Following the arrival of the coronavirus in the U.S., people with cancer and their doctors are adjusting to new ways of doing things while continuing to seek and provide cancer care.
by Kate Yandell
COVID-19 slowed or stopped enrollment in some cancer clinical trials.
Data shed light on risk factors for death among people with cancer infected with the coronavirus.
I have brain cancer, and my wife is a health care worker. These are some questions we had to consider leading up to and after her diagnosis with COVID-19.
by Adam Hayden
Identifying patients whose cancers will have durable responses to checkpoint inhibitors can guide treatment.
The FDA has expanded the use of the PARP-targeted therapeutic olaparib to include the treatment of certain patients with metastatic prostate cancer.
Bladder cancer is the sixth most prevalent cancer in the United States and has a high rate of recurrence.
Handle With Care
donate to the AACR